CEP70 and neoplasm: One of the primary benefits of BiTE and TriTE molecules is their ability to provide “specificity” to polyclonally-activated populations of T cells, resulting in resistance to tumor immune evasion strategies, such as the downregulation of Major histocompatibility complex (MHC) molecules (33).